NO841464L - Fremgangsmaate til fremstilling av nye substituerte piperazin-1-yl-eddiksyreamider - Google Patents

Fremgangsmaate til fremstilling av nye substituerte piperazin-1-yl-eddiksyreamider

Info

Publication number
NO841464L
NO841464L NO841464A NO841464A NO841464L NO 841464 L NO841464 L NO 841464L NO 841464 A NO841464 A NO 841464A NO 841464 A NO841464 A NO 841464A NO 841464 L NO841464 L NO 841464L
Authority
NO
Norway
Prior art keywords
formula
alkyl
acid
atoms
phenyl
Prior art date
Application number
NO841464A
Other languages
English (en)
Norwegian (no)
Inventor
Karl Schoenafinger
Rudi Beyerle
Ursula Schindler
Piero Martorana
Rolf-Eberhard Nitz
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of NO841464L publication Critical patent/NO841464L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO841464A 1983-04-28 1984-04-12 Fremgangsmaate til fremstilling av nye substituerte piperazin-1-yl-eddiksyreamider NO841464L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833315424 DE3315424A1 (de) 1983-04-28 1983-04-28 Substituierte piperazin-1-yl-essigsaeure-amide, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
NO841464L true NO841464L (no) 1984-10-29

Family

ID=6197594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841464A NO841464L (no) 1983-04-28 1984-04-12 Fremgangsmaate til fremstilling av nye substituerte piperazin-1-yl-eddiksyreamider

Country Status (19)

Country Link
US (1) US4610984A (fr)
EP (1) EP0123977A1 (fr)
JP (1) JPS59205363A (fr)
KR (1) KR840008347A (fr)
AU (1) AU2747384A (fr)
CA (1) CA1202304A (fr)
CS (2) CS244849B2 (fr)
DD (1) DD223711A5 (fr)
DE (1) DE3315424A1 (fr)
DK (1) DK147784A (fr)
ES (1) ES532011A0 (fr)
FI (1) FI841461A (fr)
GR (1) GR81494B (fr)
HU (1) HUT34178A (fr)
IL (1) IL71657A0 (fr)
NO (1) NO841464L (fr)
PL (2) PL253669A1 (fr)
PT (1) PT78488B (fr)
ZA (1) ZA843138B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512163D0 (en) * 1985-05-14 1985-06-19 Fujisawa Pharmaceutical Co Oxothiazolidine compound
US5110929A (en) * 1986-08-07 1992-05-05 Medice Cham.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of N-alkylated quaternary nitrogen containing aromatic heterocycles
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
DE19904710A1 (de) * 1999-02-05 2000-08-10 Aventis Pharma Gmbh Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
WO2007016496A2 (fr) * 2005-08-02 2007-02-08 Neurogen Corporation Dipipérazinyl cétones et analogues apparentés

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081564A1 (en) * 1970-03-05 1971-12-10 Delalande Sa N-amino carbonyl-piperazines analgesics - antiinflammatories ,hypotensives and spasmolytics
BE774447A (fr) * 1970-11-11 1972-02-14 Biasedra Lab Nouveaux derives de la salicylamide et leur application en therapeutique
US4247549A (en) * 1978-12-27 1981-01-27 Ici Americas Inc. Piperazine-1-carboxylic acid esters possessing antidepressant or analgesic activity
US4585774A (en) * 1981-05-08 1986-04-29 Otsuka Pharmaceutical Co., Ltd. Aniline derivatives and cardiotonic composition

Also Published As

Publication number Publication date
DK147784A (da) 1984-10-29
CS244811B2 (en) 1986-08-14
HUT34178A (en) 1985-02-28
CS121785A2 (en) 1985-09-17
CS244849B2 (en) 1986-08-14
KR840008347A (ko) 1984-12-14
AU2747384A (en) 1984-11-01
ES8502103A1 (es) 1984-12-16
DE3315424A1 (de) 1984-12-20
GR81494B (fr) 1984-12-11
JPS59205363A (ja) 1984-11-20
IL71657A0 (en) 1984-07-31
US4610984A (en) 1986-09-09
CA1202304A (fr) 1986-03-25
PT78488B (de) 1986-05-22
DD223711A5 (de) 1985-06-19
EP0123977A1 (fr) 1984-11-07
FI841461A (fi) 1984-10-29
CS307184A2 (en) 1985-09-17
PL247414A1 (en) 1985-10-08
DK147784D0 (da) 1984-02-29
ZA843138B (en) 1984-11-28
FI841461A0 (fi) 1984-04-12
PT78488A (de) 1984-05-01
PL253669A1 (en) 1986-02-11
ES532011A0 (es) 1984-12-16

Similar Documents

Publication Publication Date Title
US4374990A (en) Cyclic diamine derivatives
AU766936B2 (en) Sulfonamide-containing indole compounds
ES2298552T3 (es) Nuevos compuestos triciclicos utiles para el tratamiento de desordenes inflamatorios y alergicos; proceso para su preparacion y composiciones farmaceuticas que los contienen.
US4720493A (en) Thienylthiazole compounds
EA003023B1 (ru) Новые соединения аминотриазола, способ их получения и содержащие их фармацевтические композиции
CZ20013276A3 (cs) Nové amidové deriváty, způsob jejich přípravy a farmaceutická kompozice, která je obsahuje
DE19837386A1 (de) CCR-3-Rezeptorantagonisten
JP2010013473A (ja) 置換スルホンアミド化合物、ｃｎｓ障害、肥満およびｉｉ型糖尿病の処置のための医薬としてのそれらの使用方法
JP2001512112A (ja) フェニル環の２位で置換された１−（ｎ−フェニルアミノアルキル）−ピペラジン誘導体
EP0712397B1 (fr) Derives amides employes comme antagonistes du recepteur 5ht1d
SU1609451A3 (ru) Способ получени производных дигидробензофуран- или хроман-карбоксамидов или их аддитивных фармакологически приемлемых солей
EP3212647A2 (fr) Nouveaux composés de pyridopyrimidinone pour moduler l'activité catalytique des histone lysine déméthylases (kdm)
AU2015218775C1 (en) Antimitotic amides for the treatment of cancer and proliferative disorders
CN107438604A (zh) 新吡啶化合物
NO841464L (no) Fremgangsmaate til fremstilling av nye substituerte piperazin-1-yl-eddiksyreamider
US5648381A (en) Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof
KR101415174B1 (ko) 신규한 벤조옥사졸계 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 ｒａｇｅ 수용체 관련 질환의 예방 또는 치료용 약학적 조성물
KR101145345B1 (ko) 세포증식 억제제로서 유용한 2-싸이오-4-아미노 피리미딘 유도체 및 그 제조방법
US4115569A (en) Cyclic diamine derivatives
US4966901A (en) Pyrrole derivatives, their preparation and their use as pharmaceutical active compounds
DE3702083A1 (de) Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
JPS62153280A (ja) １，４−ジアザシクロアルカン誘導体
CN108727380A (zh) 一种brd4抑制剂及其制备和应用
WO2017034377A1 (fr) Composés de pyridopyrimidinone pour moduler l'activité catalytique des histone lysine déméthylases (kdm)
US4207319A (en) Thienyl or furyl phenyl O-hetero amino alkyl oximes and use thereof